Medicine and Dentistry
Adverse Event
7%
Antibiotic Therapy
24%
Antibiotics
43%
Bacterial Infection
70%
Blood Culture
42%
Clinician
6%
Disease Predisposition
6%
Disease Severity
6%
Diseases
13%
Escherichia coli
10%
Immune Response
6%
Infection
8%
Intention-to-Treat Analysis
11%
Laboratory Test
14%
Meta-Analysis
14%
Neonatal Sepsis
66%
Neonates
100%
Newborn Period
6%
Noninferiority Trial
33%
Patient Characteristics
6%
Personalized Medicine
33%
Pharmacokinetics
6%
Polymerase Chain Reaction
33%
Prospective Cohort Study
33%
Randomized Clinical Trial
66%
Randomized Controlled Trial
23%
Reinfection
11%
Sepsis
49%
Streptococcus Agalactiae
13%
Systematic Review
33%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
9%
Amoxicillin
51%
Antibiotic Therapy
9%
Antibiotics
33%
Bacterial Infection
40%
Beta Lactamase
33%
Bioavailability
6%
Clavulanic Acid
71%
Diseases
8%
Noninferiority Trial
33%
Pharmacokinetics
100%
Prematurity
6%
Reinfection
14%
